Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2013

01.08.2013 | Key Review Article

The Spread of the J Project

verfasst von: Zsuzsa Horváth, Nima Rezaei, Ismail Reisli, Irina Tuzankina, Nurzhan Otarbayev, Panteley Popandopulo, László Maródi

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The J Project physician education and clinical research collaboration program was launched in 2004 in Eastern and Central Europe (ECE). In less than 10 years, it has achieved remarkable success. This project aims to increase knowledge in the field of primary immunodeficiency disorders (PID), and to improve the diagnosis and treatment of patients worldwide, particularly in countries with limited economic resources, which currently report fewer such patients than expected. In most ECE countries, gene sequencing, which can provide a definitive diagnosis of PID, still remains unavailable. By contrast, such technology is used elsewhere to detect the more than 200 PID-causing genes that have been discovered in the last three decades. Thus, PID awareness programs like the J Project remain critically important, to improve diagnostic facilities and treatment and to promote clinical research collaboration. This paper highlights the achievements of the J Project and the spread of its concepts and spirit to the countries of Western Asia.
Literatur
1.
Zurück zum Zitat Maródi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol. 2007;7:851–61.PubMedCrossRef Maródi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol. 2007;7:851–61.PubMedCrossRef
2.
Zurück zum Zitat Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.PubMedCrossRef Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.PubMedCrossRef
4.
Zurück zum Zitat Maródi L. The creation and progress of the J Project in Eastern and Central Europe. Ann NY Acad Sci. 2011;1238:65–73.PubMedCrossRef Maródi L. The creation and progress of the J Project in Eastern and Central Europe. Ann NY Acad Sci. 2011;1238:65–73.PubMedCrossRef
5.
Zurück zum Zitat Maródi L, Casanova JL. Primary immunodeficiency diseases: the J Project. Lancet. 2009;373:2179–81.PubMedCrossRef Maródi L, Casanova JL. Primary immunodeficiency diseases: the J Project. Lancet. 2009;373:2179–81.PubMedCrossRef
6.
Zurück zum Zitat Maródi L, Notarangelo LD. Education and worldwide collaboration pays off. Nat Immunol. 2007;8:323–4.PubMedCrossRef Maródi L, Notarangelo LD. Education and worldwide collaboration pays off. Nat Immunol. 2007;8:323–4.PubMedCrossRef
7.
Zurück zum Zitat Tóth B, Volokha A, Mihas A, Pac M, Bernatowska E, Kondratenko I, et al. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. Mol Immunol. 2009;46:2140–6.PubMedCrossRef Tóth B, Volokha A, Mihas A, Pac M, Bernatowska E, Kondratenko I, et al. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. Mol Immunol. 2009;46:2140–6.PubMedCrossRef
8.
Zurück zum Zitat Gulácsy V, Freiberger T, Shcherbina A, Pac M, Chernyshova L, Avcin T, et al. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome. Mol Immunol. 2011;48:788–92.PubMedCrossRef Gulácsy V, Freiberger T, Shcherbina A, Pac M, Chernyshova L, Avcin T, et al. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome. Mol Immunol. 2011;48:788–92.PubMedCrossRef
9.
Zurück zum Zitat Tuzankina I, Kobeleva Y, Kiseleva N, Bolkov M, Reuter G, Maródi L. Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease. Allergy. 2011;66:1617–8.PubMedCrossRef Tuzankina I, Kobeleva Y, Kiseleva N, Bolkov M, Reuter G, Maródi L. Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodegenerative disease. Allergy. 2011;66:1617–8.PubMedCrossRef
10.
Zurück zum Zitat Tóth B, Wolff AS, Halász Z, Tar A, Szüts P, Ilyés I, et al. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy. Clin Endocrinol. 2010;72:641–7.CrossRef Tóth B, Wolff AS, Halász Z, Tar A, Szüts P, Ilyés I, et al. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy. Clin Endocrinol. 2010;72:641–7.CrossRef
11.
Zurück zum Zitat Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)-diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.PubMedCrossRef Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)-diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.PubMedCrossRef
12.
Zurück zum Zitat Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann NY Acad Sci. 2011;1238:15–23.PubMedCrossRef Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann NY Acad Sci. 2011;1238:15–23.PubMedCrossRef
13.
Zurück zum Zitat Azarsiz E, Gulez N, Edeer KN, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiencies: a single centre study. J Clin Immunol. 2011;31:106–11.PubMedCrossRef Azarsiz E, Gulez N, Edeer KN, Aksu G, Kutukculer N. Consanguinity rate and delay in diagnosis in Turkish patients with combined immunodeficiencies: a single centre study. J Clin Immunol. 2011;31:106–11.PubMedCrossRef
14.
Zurück zum Zitat Yorulmaz A, Artaç H, Kara R, Keleş S, Reisli İ. Retrospective evaluation of 1054 patients with primary immunodeficiency (in Turkish). Allergy Asthma Immunol. 2008;6:127–34. Yorulmaz A, Artaç H, Kara R, Keleş S, Reisli İ. Retrospective evaluation of 1054 patients with primary immunodeficiency (in Turkish). Allergy Asthma Immunol. 2008;6:127–34.
15.
Zurück zum Zitat CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264–72.CrossRef CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264–72.CrossRef
16.
Zurück zum Zitat Rezaei N, Mohammadinejad P, Aghamohammadi A. The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment. Ann N Y Acad Sci. 2011;1238:24–32.PubMedCrossRef Rezaei N, Mohammadinejad P, Aghamohammadi A. The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment. Ann N Y Acad Sci. 2011;1238:24–32.PubMedCrossRef
17.
Zurück zum Zitat Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in Iran. Iran J Pediatr. 2010;20:16–34.PubMed Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in Iran. Iran J Pediatr. 2010;20:16–34.PubMed
18.
Zurück zum Zitat Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519–32.PubMedCrossRef Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519–32.PubMedCrossRef
19.
Zurück zum Zitat Rezaei N, Aghamohammadi A, Notarangelo LD. Primary immunodeficiency diseases: Definition, diagnosis and management. Berlin Heidelberg: Springer; 2008.CrossRef Rezaei N, Aghamohammadi A, Notarangelo LD. Primary immunodeficiency diseases: Definition, diagnosis and management. Berlin Heidelberg: Springer; 2008.CrossRef
20.
Zurück zum Zitat Nourijelyani K, Aghamohammadi A, Salehi SM, Behniafard N, Abolhassani H, Pourjabar S, et al. Physicians’ awareness on primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2012;11:57–64.PubMed Nourijelyani K, Aghamohammadi A, Salehi SM, Behniafard N, Abolhassani H, Pourjabar S, et al. Physicians’ awareness on primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2012;11:57–64.PubMed
21.
Zurück zum Zitat Mahdaviani SA, Hirbod-Mobarakeh A, Wang N, Aghamohammadi A, Hammarström L, Masjedi MR, et al. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome. Expert Rev Clin Immunol. 2012;8:539–46.PubMedCrossRef Mahdaviani SA, Hirbod-Mobarakeh A, Wang N, Aghamohammadi A, Hammarström L, Masjedi MR, et al. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome. Expert Rev Clin Immunol. 2012;8:539–46.PubMedCrossRef
Metadaten
Titel
The Spread of the J Project
verfasst von
Zsuzsa Horváth
Nima Rezaei
Ismail Reisli
Irina Tuzankina
Nurzhan Otarbayev
Panteley Popandopulo
László Maródi
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2013
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9905-2

Weitere Artikel der Ausgabe 6/2013

Journal of Clinical Immunology 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.